Atypical movement disorders in antiphospholipid syndrome.
Identifieur interne : 001598 ( Ncbi/Checkpoint ); précédent : 001597; suivant : 001599Atypical movement disorders in antiphospholipid syndrome.
Auteurs : Davide Martino [Royaume-Uni] ; Nee-Kong Chew ; Pablo Mir ; Mark J. Edwards ; Niall P. Quinn ; Kailash P. BhatiaSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2006.
English descriptors
- KwdEn :
- Adolescent, Antiphospholipid Syndrome (diagnosis), Antiphospholipid Syndrome (drug therapy), Antiphospholipid Syndrome (physiopathology), Brain (pathology), Brain (physiopathology), Cerebral Infarction (diagnosis), Cerebral Infarction (drug therapy), Cerebral Infarction (physiopathology), Diagnosis, Differential, Dyskinesias (diagnosis), Dyskinesias (drug therapy), Dyskinesias (physiopathology), Electroencephalography (drug effects), Electromyography (drug effects), Female, Follow-Up Studies, Frontal Lobe (pathology), Frontal Lobe (physiopathology), Humans, Lupus Erythematosus, Systemic (diagnosis), Lupus Erythematosus, Systemic (drug therapy), Lupus Erythematosus, Systemic (physiopathology), Magnetic Resonance Imaging, Middle Aged, Movement Disorders (diagnosis), Movement Disorders (drug therapy), Movement Disorders (physiopathology), Myoclonus (diagnosis), Myoclonus (drug therapy), Myoclonus (physiopathology), Neurologic Examination (drug effects), Neuropsychological Tests, Occipital Lobe (pathology), Occipital Lobe (physiopathology), Phenindione (therapeutic use), Phenprocoumon (therapeutic use), Sneddon Syndrome (diagnosis), Sneddon Syndrome (drug therapy), Sneddon Syndrome (physiopathology), Spinocerebellar Degenerations (diagnosis), Spinocerebellar Degenerations (drug therapy), Spinocerebellar Degenerations (physiopathology), Tics (diagnosis), Tics (drug therapy), Tics (physiopathology), Tourette Syndrome (diagnosis), Tourette Syndrome (drug therapy), Tourette Syndrome (physiopathology), Tremor (diagnosis), Tremor (drug therapy), Tremor (physiopathology), Warfarin (therapeutic use).
- MESH :
- chemical , therapeutic use : Phenindione, Phenprocoumon, Warfarin.
- diagnosis : Antiphospholipid Syndrome, Cerebral Infarction, Dyskinesias, Lupus Erythematosus, Systemic, Movement Disorders, Myoclonus, Sneddon Syndrome, Spinocerebellar Degenerations, Tics, Tourette Syndrome, Tremor.
- drug effects : Electroencephalography, Electromyography, Neurologic Examination.
- drug therapy : Antiphospholipid Syndrome, Cerebral Infarction, Dyskinesias, Lupus Erythematosus, Systemic, Movement Disorders, Myoclonus, Sneddon Syndrome, Spinocerebellar Degenerations, Tics, Tourette Syndrome, Tremor.
- pathology : Brain, Frontal Lobe, Occipital Lobe.
- physiopathology : Antiphospholipid Syndrome, Brain, Cerebral Infarction, Dyskinesias, Frontal Lobe, Lupus Erythematosus, Systemic, Movement Disorders, Myoclonus, Occipital Lobe, Sneddon Syndrome, Spinocerebellar Degenerations, Tics, Tourette Syndrome, Tremor.
- Adolescent, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Middle Aged, Neuropsychological Tests.
Abstract
Movement disorders have only rarely been reported in association with antiphospholipid syndrome (APS). In such cases, chorea is the most common disorder observed, with occasional reports of hemidystonia, Parkinsonism, and hemiballism. We report here on 3 cases of APS (3 women ages 16, 46, and 56 years) who presented with movement disorders, including tics, tremor, myoclonus, and a corticobasal syndrome, never or rarely reported in association with this disease. Mild executive dysfunction was observed in all 3 patients. We also report the successful treatment of two of these patients with mild oral anticoagulation (INR 2-3). Movement disorders in APS seem more clinically heterogeneous than previously thought. Oral anticoagulation should be considered in the treatment of movement disorders associated with APS.
DOI: 10.1002/mds.20842
PubMed: 16538618
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002D33
- to stream PubMed, to step Curation: 002D33
- to stream PubMed, to step Checkpoint: 002E65
- to stream Ncbi, to step Merge: 001598
- to stream Ncbi, to step Curation: 001598
Links to Exploration step
pubmed:16538618Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Atypical movement disorders in antiphospholipid syndrome.</title>
<author><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
<affiliation wicri:level="3"><nlm:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chew, Nee Kong" sort="Chew, Nee Kong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
</author>
<author><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
</author>
<author><name sortKey="Edwards, Mark J" sort="Edwards, Mark J" uniqKey="Edwards M" first="Mark J" last="Edwards">Mark J. Edwards</name>
</author>
<author><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P" last="Quinn">Niall P. Quinn</name>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P" last="Bhatia">Kailash P. Bhatia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="doi">10.1002/mds.20842</idno>
<idno type="RBID">pubmed:16538618</idno>
<idno type="pmid">16538618</idno>
<idno type="wicri:Area/PubMed/Corpus">002D33</idno>
<idno type="wicri:Area/PubMed/Curation">002D33</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E65</idno>
<idno type="wicri:Area/Ncbi/Merge">001598</idno>
<idno type="wicri:Area/Ncbi/Curation">001598</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001598</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Atypical movement disorders in antiphospholipid syndrome.</title>
<author><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
<affiliation wicri:level="3"><nlm:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chew, Nee Kong" sort="Chew, Nee Kong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
</author>
<author><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
</author>
<author><name sortKey="Edwards, Mark J" sort="Edwards, Mark J" uniqKey="Edwards M" first="Mark J" last="Edwards">Mark J. Edwards</name>
</author>
<author><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P" last="Quinn">Niall P. Quinn</name>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P" last="Bhatia">Kailash P. Bhatia</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Antiphospholipid Syndrome (diagnosis)</term>
<term>Antiphospholipid Syndrome (drug therapy)</term>
<term>Antiphospholipid Syndrome (physiopathology)</term>
<term>Brain (pathology)</term>
<term>Brain (physiopathology)</term>
<term>Cerebral Infarction (diagnosis)</term>
<term>Cerebral Infarction (drug therapy)</term>
<term>Cerebral Infarction (physiopathology)</term>
<term>Diagnosis, Differential</term>
<term>Dyskinesias (diagnosis)</term>
<term>Dyskinesias (drug therapy)</term>
<term>Dyskinesias (physiopathology)</term>
<term>Electroencephalography (drug effects)</term>
<term>Electromyography (drug effects)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Frontal Lobe (pathology)</term>
<term>Frontal Lobe (physiopathology)</term>
<term>Humans</term>
<term>Lupus Erythematosus, Systemic (diagnosis)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Lupus Erythematosus, Systemic (physiopathology)</term>
<term>Magnetic Resonance Imaging</term>
<term>Middle Aged</term>
<term>Movement Disorders (diagnosis)</term>
<term>Movement Disorders (drug therapy)</term>
<term>Movement Disorders (physiopathology)</term>
<term>Myoclonus (diagnosis)</term>
<term>Myoclonus (drug therapy)</term>
<term>Myoclonus (physiopathology)</term>
<term>Neurologic Examination (drug effects)</term>
<term>Neuropsychological Tests</term>
<term>Occipital Lobe (pathology)</term>
<term>Occipital Lobe (physiopathology)</term>
<term>Phenindione (therapeutic use)</term>
<term>Phenprocoumon (therapeutic use)</term>
<term>Sneddon Syndrome (diagnosis)</term>
<term>Sneddon Syndrome (drug therapy)</term>
<term>Sneddon Syndrome (physiopathology)</term>
<term>Spinocerebellar Degenerations (diagnosis)</term>
<term>Spinocerebellar Degenerations (drug therapy)</term>
<term>Spinocerebellar Degenerations (physiopathology)</term>
<term>Tics (diagnosis)</term>
<term>Tics (drug therapy)</term>
<term>Tics (physiopathology)</term>
<term>Tourette Syndrome (diagnosis)</term>
<term>Tourette Syndrome (drug therapy)</term>
<term>Tourette Syndrome (physiopathology)</term>
<term>Tremor (diagnosis)</term>
<term>Tremor (drug therapy)</term>
<term>Tremor (physiopathology)</term>
<term>Warfarin (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Phenindione</term>
<term>Phenprocoumon</term>
<term>Warfarin</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Cerebral Infarction</term>
<term>Dyskinesias</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Movement Disorders</term>
<term>Myoclonus</term>
<term>Sneddon Syndrome</term>
<term>Spinocerebellar Degenerations</term>
<term>Tics</term>
<term>Tourette Syndrome</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Electroencephalography</term>
<term>Electromyography</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Cerebral Infarction</term>
<term>Dyskinesias</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Movement Disorders</term>
<term>Myoclonus</term>
<term>Sneddon Syndrome</term>
<term>Spinocerebellar Degenerations</term>
<term>Tics</term>
<term>Tourette Syndrome</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
<term>Frontal Lobe</term>
<term>Occipital Lobe</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Brain</term>
<term>Cerebral Infarction</term>
<term>Dyskinesias</term>
<term>Frontal Lobe</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Movement Disorders</term>
<term>Myoclonus</term>
<term>Occipital Lobe</term>
<term>Sneddon Syndrome</term>
<term>Spinocerebellar Degenerations</term>
<term>Tics</term>
<term>Tourette Syndrome</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Movement disorders have only rarely been reported in association with antiphospholipid syndrome (APS). In such cases, chorea is the most common disorder observed, with occasional reports of hemidystonia, Parkinsonism, and hemiballism. We report here on 3 cases of APS (3 women ages 16, 46, and 56 years) who presented with movement disorders, including tics, tremor, myoclonus, and a corticobasal syndrome, never or rarely reported in association with this disease. Mild executive dysfunction was observed in all 3 patients. We also report the successful treatment of two of these patients with mild oral anticoagulation (INR 2-3). Movement disorders in APS seem more clinically heterogeneous than previously thought. Oral anticoagulation should be considered in the treatment of movement disorders associated with APS.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P" last="Bhatia">Kailash P. Bhatia</name>
<name sortKey="Chew, Nee Kong" sort="Chew, Nee Kong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
<name sortKey="Edwards, Mark J" sort="Edwards, Mark J" uniqKey="Edwards M" first="Mark J" last="Edwards">Mark J. Edwards</name>
<name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
<name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P" last="Quinn">Niall P. Quinn</name>
</noCountry>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001598 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001598 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:16538618 |texte= Atypical movement disorders in antiphospholipid syndrome. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:16538618" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |